EXCExelon

$44.44-3.6% 1Y

Is the price fair?

Fair

Neither cheap nor expensive: in its normal P/E range and in line with its sector.

2 neutral, 1 without data
Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 15.9 vs a 12.1 median over 30 quarters (+32% vs median).

Vs sector (EV/EBIT)18.3×derived · Jun 30, 2026

Sector median 21.3× across 56 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What EXC's price assumes

Exelon has no trailing P/E on file, so the price is measured against sales instead: 1.81× revenue.

1.81

Price / sales · no trailing P/E on file: measured against sales instead

Price / book
1.54

Price / book · today's price, trailing year to Jun 30, 2026

EV / sales
3.80

EV / sales

Details›
Price / booktoday's price, trailing year to Jun 30, 2026
1.54
EV / EBITtoday's price, trailing year to Jun 30, 2026
18.3
EV / salestoday's price, trailing year to Jun 30, 2026
3.80
Market capitalisation1.03 billion shares, counted Jun 30, 2026
$45.9B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

Against its own past

Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.